News - The Clinic of Change

News

Champalimaud Foundation welcomes international experts to talk about psychedelic-assisted therapies

Safety, regulation, therapeutic practices and future directions will be issues addressed throughout the day, with a view to ensuring "equitable access to psychedelic-assisted care."

Hospital de Beja realiza primeira administração de escetamina no SNS, no tratamento da depressão

A notable milestone, since this is the first time this therapy has been used in the National Health Service since Infarmed approved its funding on May 7th of this year.

Cetamina e escetamina melhoram qualidade de vida de doentes com depressão grave e resistente, aponta estudo

A new study carried out by Canadian experts concludes that the use of ketamine and esketamine in the treatment of severe depression (major depressive disorder) and treatment-resistant depression can lead to a substantial improvement in the quality of life of the respective patients.

Norway approves reimbursement for ketamine-assisted treatment in all public hospitals

After months of consideration and years of studies, the Norwegian regulatory authorities have approved public funding for off-label intravenous ketamine treatment for patients diagnosed with resistant depression. This is now guaranteed by the country's national health service throughout its territory.

ADHD: more than a million new diagnoses in recent years

In the United States, for example, it is estimated that around 1 in 9 children have already received this diagnosis. In Europe too, the number of families seeking specialized assessment has grown significantly. What explains this trend?

Infarmed-approved ketamine treatment available at The Clinic of Change

At The Clinic of Change, this innovative treatment is now available, as part of a rigorous protocol supervised by specialized health professionals.

Esketamine: an effective alternative for treating major depression

A case study published in the journal Frontiers in Psychiatry has reinforced the therapeutic potential of intranasal esketamine as a viable alternative in situations of high therapeutic resistance.

EXPRESSO: "Almost 600 Portuguese have already been treated with psychedelics"

The growing scientific evidence and careful implementation of these therapies position Portugal as a leader in the integration of innovative approaches in the field of mental health.